Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first...

por Lee, S, Park, Y H, Kim, K H, Cho, E Y, Ahn, Y C, Kim, K, Shim, Y-M, Ahn, J S, Park, K, Im, Y-H
Publicado 2010

A single institutional experience of thymic epithelial tumours over 11 years: clinical features and outcome and implications for future management

por Lee, H-S, Kim, S T, Lee, J, Choi, Y S, Han, J-H, Ahn, Y-C, Lee, K-S, Ahn, J S, Ahn, M J, Kim, K, Shim, Y M, Kim, J, Park, K
Publicado 2007

Adjuvant durvalumab for esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a placebo-controlled, randomized, double-blind, phase II study

por Park, S., Sun, J.-M., Choi, Y.-L., Oh, D., Kim, H.K., Lee, T., Chi, S.A., Lee, S.-H., Choi, Y.S., Jung, S.-H., Ahn, M.-J., Ahn, Y.C., Park, K., Shim, Y.M.
Publicado 2022